Women with low levels of pregnancy-associated plasma protein A (PAPP-A) during the first 10 weeks of pregnancy are forty times more likely to have a stillbirth later in pregnancy, according to a multicenter, prospective cohort study conducted in Scotland.
Women with low levels of pregnancy-associated plasma protein A (PAPP-A) during the first 10 weeks of pregnancy are forty times more likely to have a stillbirth later in pregnancy, according to a multicenter, prospective cohort study conducted in Scotland.
The study included almost 8,000 women. Researchers calculated eight stillbirths among 400 women with levels of PAPP-A at or below the fifth percentile compared with 17 among the remaining 7,534 women, for an incidence rate per 10,000 women per week of gestation of 13.4 versus 1.4, respectively (hazard ratio 9.2 [95% CI 4.0-21.4]; P<0.001). The stillbirths associated with low levels of PAPP-A were due to placental dysfunction, defined as abruption or unexplained stillbirth associated with growth restriction; there was no association with other causes of stillbirth.
The researchers found no relationship between low PAPP-A and maternal age, ethnicity, parity, height, body mass index, race, or marital status, nor between another placental protein-free β subunit of human chorionic gonadotropin (hCG)-and the risk of stillbirth.
SART data indicates rise in IVF use in 2022
April 24th 2024Dive into the latest statistics from the Society for Assisted Reproductive Technology, revealing a 6% increase in in vitro fertilization cycles and a surge in egg freezing, amidst a landscape of rising fertility service demand and evolving clinical practices.
Read More
Hormone therapy safety: Study finds potential benefits for senior women
April 24th 2024A recent large-scale study challenged age-related concerns, suggesting hormone therapy may offer safety and even benefits for menopausal women aged over 65 years, aligning with The Menopause Society's 2022 Position Statement.
Read More